Romanian guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency

Journal of Gastrointestinal and Liver Diseases

Volumn 24, Issue 1, 2015, Pages 117-123

  Gheorghe, Cristian ^a,b   Seicean, Andrada ^c,d   Saftoiu, Adrian ^e,f   Tantau, Marcel ^c,d   Dumitru, Eugen ^g   Jinga, Mariana ^a,h   Negreanu, Lucian ^a,i   Mateescu, Bogdan ^a,j   Gheorghe, Liana ^a,b   Ciocirlan, Mihai ^a,b   Cijevschi, Cristina ^k,l   Constantinescu, Gabriel ^a,m   Dima, Simona ^a,b   Diculescu, Mircea ^a,b  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d REGIONAL INSTITUTE OF GASTROENTEROLOGY AND HEPATOLOGY   (Romania)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^g OVIDIUS UNIVERSITY   (Romania)

^h Medicine and Gastroenterology Clinic Carol Davila Central University Emergency Military Hospital   (Romania)

ⁱ Emergency University Clinical Hospital   (Romania)

^j V Babes National Institute of Pathology   (Romania)

^k GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^l Institute of Gastroenterology and Hepatology   (Romania)

^m Floreasca Emergency Hospital   (Romania)

more..

Author keywords

Chronic pancreatitis; Enzyme replacement therapy; Exocrine pancreatic insufficiency; Guidelines

Indexed keywords

PANCREAS ENZYME; PANCRELIPASE; PROTON PUMP INHIBITOR; TRIACYLGLYCEROL LIPASE;

ACUTE PANCREATITIS; ARTICLE; CELIAC DISEASE; CHRONIC PANCREATITIS; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME REPLACEMENT; GLUTEN FREE DIET; HUMAN; LIPID ABSORPTION; LIPID DIET; MALABSORPTION; METEORISM; MULTICENTER STUDY (TOPIC); NUTRITIONAL STATUS; PANCREAS CANCER; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS FUNCTION; PANCREAS FUNCTION TEST; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); TREATMENT FAILURE; TREATMENT RESPONSE; WEIGHT REDUCTION; ADVERSE EFFECTS; ENZYMOLOGY; EXOCRINE PANCREATIC INSUFFICIENCY; PREDICTIVE VALUE; ROMANIA; STANDARDS; TIME FACTOR; TREATMENT OUTCOME;

ENZYME REPLACEMENT THERAPY; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; PANCREATIC FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; ROMANIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84924145943     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Oxford Centre for Evidence-based Medicine-Levels of Evidence (March 2009). Available at: http://www. cebm. net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/(Accessed October 2014).
2. Ammann RW, Muellhaupt B, Meyenberger C, Heitz PU. Alcoholic nonprogressive chronic pancreatitis: prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976-1992). Pancreas 1994; 9: 365-373.
3. Frulloni L, Scattolini C, Katsotourchi AM, et al. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment. Pancreatology 2010; 10: 129-133. doi: 10. 1159/000265945.
4. Xu Y, Wu D, Zeng Y, Wang X. Pancreatic exocrine function and morphology following an episode of acute pancreatitis. Pancreas 2012; 41: 922-927. doi: 10. 1097/MPA. 0b013e31823d7f2d.
5. Sikkens EC, Cahen DL, de Wit J, Looman CW, van Eijck C, Bruno MJ. A prospective assessment of the natural course of the exocrine pancreatic function in patients with apancreatic head tumor. J Clin Gastroenterol 2014; 48: e43-e46. doi: 10. 1097/MCG. 0b013e31829f56e7.
6. Halloran CM, Cox TF, Chauhan S, et al. Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrinefailure and reduced quality of life: a prospective study. Pancreatology 2011; 11: 535-545. doi: 10. 1159/000333308.
7. Diener MK, Rahbari NN, Fischer L, Antes G, Büchler MW, Seiler CM. Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for surgical treatment of chronic pancreatitis: a systematic review and meta-analysis. Ann Surg 2008; 247: 950-961. doi: 10. 1097/SLA. 0b013e3181724ee7.
8. Speicher JE, Traverso LW. Pancreatic exocrine function is preserved after distal pancreatectomy. J Gastrointest Surg 2010; 14: 1006-1011. doi: 10. 1007/s11605-010-1184-0.
9. Leeds JS, Hopper AD, Hurlstone DP, et al. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther 2007; 25: 265-271. doi: 10. 1111/j. 1365-2036. 2006. 03206. x.
10. Baker SS. Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis. Ther Clin Risk Manag 2008; 4: 1079-1084. doi: 10. 2147/TCRM. S3123.
11. Barthet M, Lesavre N, Desplats S, et al. Frequency and characteristics of pancreatitis in patients with inflammatory bowel disease. Pancreatology 2006; 6: 464-471. doi: 10. 1159/000094564.
12. Maconi G, Dominici R, Molteni M, et al. Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1. Dig Dis Sci 2008; 53: 262-270. doi: 10. 1007/s10620-007-9852-y.
13. Hardt PD, Hauenschild A, Nalop J, et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1, 021 diabetic patients. Pancreatology 2003; 3: 395-402. doi: 10. 1159/000073655.
14. Vujasinovic M, Zaletel J, Tepes B, et al. Low prevalence of exocrine pancreatic insufficiency in patients with diabetes mellitus. Pancreatology 2013; 13: 343-346. doi: 10. 1016/j. pan. 2013. 05. 010.
15. Pezzilli R, Andriulli A, Bassi C, et al. Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas. World J Gastroenterol 2013; 19: 7930-7946. doi: 10. 3748/wjg. v19. i44. 7930.
16. Stevens T, Conwell DL, Zuccaro G Jr, et al. A prospective crossover study comparing secretin-stimulated endoscopic and Dreiling tube pancreatic function testing in patients evaluated for chronic pancreatitis. Gastrointest Endosc 2008; 67: 458-466. doi: 10. 1016/j. gie. 2007. 07. 028.
17. Schneider AR, Hammerstingl R, Heller M, et al. Does secretin-stimulated MRCP predict exocrine pancreatic insufficiency? A comparison with noninvasive exocrine pancreatic function tests. J Clin Gastroenterol 2006; 40: 851-855. doi: 10. 1097/01. mcg. 0000225652. 00308. a2.
18. Chronic Pancreatitis German Society of Digestive and Metabolic Diseases (DGVS), Hoffmeister A, Mayerle J, et al. S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS). Z Gastroenterol 2012; 50: 1176-224. doi: 10. 1055/s-0032-1325479.
19. Takács T, Czakó L, Dubravcsik Zs, et al. Chronic pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group 2014. Orv Hetil 2015; 156: 262-288.
20. Amann ST, Bishop M, Curington C, Toskes PP. Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis. Pancreas 1996; 13: 226-230.
21. Naruse S, Ishiguro H, Ko SB, et al. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. J Gastroenterol 2006; 41: 901-908. doi: 10. 1007/s00535-006-1884-0.
22. Hahn JU, Kerner W, Maisonneuve P, Lowenfels AB, Lankisch PG. Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus. Pancreas 2008; 36: 274-278. doi: 10. 1097/MPA. 0b013e3181656f8.
23. Wali PD, Loveridge-Lenza B, He Z, Horvath K. Comparison of fecal elastase-1 and pancreatic function testing in children. J Pediatr Gastroenterol Nutr 2012; 54: 277-280. doi: 10. 1097/MPG. 0b013e31820b0227.
24. Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 484-488. doi: 10. 1016/j. cgh. 2007. 01. 004.
25. Sikkens EC, Cahen DL, Kuipers EJ, Bruno MJ. Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010; 24: 337-347. doi: 10. 1016/j. bpg. 2010. 03. 006.
26. D'Haese JG, Ceyhan GO, Demir IE, et al. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life. Pancreas 2014; 43: 834-841. doi: 10. 1097/MPA. 0000000000000131.
27. Ramesh H, Reddy N, Bhatia S, et al. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology 2013; 13: 133-139. doi: 10. 1016/j. pan. 2013. 01. 009.
28. Whitcomb DC, Lehman GA, Vasileva G, et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol 2010; 105: 2276-2286. doi: 10. 1038/ajg. 2010. 201.
29. Winny M, Paroglou V, Bektas H, et al. Insulin dependence and pancreatic enzyme replacement therapy are independent prognostic factors for long-term survival after operation for chronic pancreatitis. Surgery 2014; 155: 271-279. doi: 10. 1016/j. surg. 2013. 08. 012.
30. O'Sullivan BP, Baker D, Leung KG, Reed G, Baker SS, Borowitz D. Evolution of pancreatic function during the first year in infants with cystic fibrosis. J Pediatr 2013; 162: 808-812. e1. doi: 10. 1016/j. jpeds. 2012. 10. 008.
31. Colombo C, Fredella C, Russo MC, et al. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Pancreas 2009; 38: 693-699. doi: 10. 1097/MPA. 0b013e3181a85eaf.
32. Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002; 1: 51-75.
33. Luaces-Regueira M, Iglesias-García J, Lindkvist B, et al. Smoking as a risk factor for complications in chronic pancreatitis. Pancreas 2014; 43: 275-280. doi: 10. 1097/01. mpa. 0000437324. 52598.
34. Stallings VA, Stark LJ, Robinson KA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008; 108: 832-839. doi: 10. 1016/j. jada. 2008. 02. 020.
35. de-Madaria E, Abad-González A, Aparicio JR, et al. The Spanish Pancreatic Club's recommendations for the diagnosis and treatment of chronic pancreatitis: part 2 (treatment). Pancreatology 2013; 13: 18-28. doi: 10. 1016/j. pan. 2012. 11. 310.
36. Olveira G, Olveira C. Nutrition, cystic fibrosis and the digestive tract. Nutr Hosp 2008; 23 Suppl 2: 71-86.
37. Afghani E, Sinha A, Singh VK. An overview of the diagnosis and management of nutrition in chronic pancreatitis. Nutr Clin Pract 2014; 29: 295-311. doi: 10. 1177/0884533614529996.
38. Taylor JR, Gardner TB, Waljee AK, Dimagno MJ, Schoenfeld PS. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency. Aliment Pharmacol Ther 2010; 31: 57-72. doi: 10. 1111/j. 1365-2036. 2009. 04157. x.
39. Czako L, Takacs T, Hegyi P, et al. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis. Can J Gastroenterol 2003; 17: 597-603.
40. Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010; 42: S381-S406. doi: 10. 1016/S1590-8658(10)60682-2.
41. Domínguez-Muñoz JE, Iglesias-García J, Iglesias-Rey M, Figueiras A, Vilariño-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther 2005; 21: 993-1000. doi: 10. 1111/j. 1365-2036. 2005. 02390. x.
42. Löhr JM, Oliver MR, Frulloni L. Synopsis of recent guidelines on pancreatic exocrine insufficiency. United European Gastroenterol J 2013; 1: 79-83. doi: 10. 1177/2050640613476500.
43. Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut 2005; 54: 1-28. doi: 10. 1136/gut. 2005. 065946.
44. Toouli J, Biankin AV, Oliver MR, et al. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. Med J Aust 2010; 193: 461-467.